Stax Provides Sell-Side Support to BioProcure-Prendio, Receiving Strategic Growth Investment from Primus Capital

Stax Provides Sell-Side Support to BioProcure-Prendio, Receiving Strategic Growth Investment from Primus Capital

November 3, 2023
November 3, 2023

Share

Stax is pleased to congratulate BioProcure and its sister company, Prendio, on their recent growth equity investment from Primus Capital. Stax provided sell-side support collaborating with the management teams of BioProcure and Prendio and Aeris Partners.


Since 2007, BioProcure has significantly contributed to the success of numerous global life science companies. An industry-leading provider of procure-to-pay enabled services for biotech, BioProcure offers procurement services, accounts payable support, and administrative assistance to research organizations. 

 

Prendio is a leading provider of cloud-based eProcurement SaaS and supplier marketplace solutions tailored for the life science sector. Developed by a team with over 50 years of experience in biotech procurement and lab management, Prendio software addresses the challenges faced by research teams dealing with complex procure-to-pay systems. It offers an affordable, user-friendly, and scalable solution, ultimately speeding up the progress of life science teams. 

For more details on our experience in the space, please contact the Stax team: 

BioProcure-Prendio logo
Primus logo
BioProcure-Prendio logo
Primus logo

For more details on our experience in the space, please contact the Stax team: 

Image of Rob Larson

Paul Edwards

Global Practice Lead

Image of Rob Larson

Rob Larson

Managing Director

About Stax

Stax is a global management consulting firm serving corporate and private equity clients across a broad range of industries including software/technology, industrials, business and information services, healthcare and HCIT, consumer, and tradeshows and events. 

Read More

The Final 12 Months Before Exit: Building the Next Buyer’s Investment Case
By Paul Edwards June 11, 2026
Global Practice Leader Paul Edwards highlights the value of the final year before a sale and how investors can utilize this time to generate better outcomes. Read more.
The US Early Childhood Education Market: Growth Requires a Focused Expansion Playbook
By Miriam El-Baz & Alex Erines June 11, 2026
The US ECE market remains an attractive growth arena for operators, product and service providers, and investors. Read what insights Miriam El-Baz and Alex Erines have to share.
How Leading Events Organisers Ambitions Are Evolving Intelligence: Key Takeaways from Monetising B2B
By Florent Jarry & Bharath Venkatesh June 5, 2026
Florent Jarry and Bharath Venkatesh attended Monetising B2B a conference hosted in London in May 2026. Read their full report on their learnings here.
Feat. by ION Analytics: Hospice M&A Rebounds, Assets in Short Supply
June 4, 2026
Rob Larson was interviewed by ION Analytics to discuss the recent trends in hospice M&A and what is driving investors to make these moves. Read the full article here.
The Second Institutional Exit Has Changed: What Buyers Underwrite Today
By Paul Edwards June 3, 2026
The market for second institutional exits has become more demanding. Global Practice Leader Paul Edwards breaks down what he has observed and how companies can attract high-value buyers.
Featured by Wall Street Journal: Private Equity Looks to Consolidate HOA Management Companies
June 2, 2026
Tyler Veit was quoted in The Wall Street Journal's recent article, sharing his thoughts on the fragmentation challenges facing investors while also providing a positive outlook. Read more.
Show More